Standard usage and dosage of avatrombopag (Sucoxin) and patient-specific adjustment plan

Avatrombopag is an oral thrombopoietin receptor (TPO-R) agonist that promotes bone marrow megakaryocyte proliferation and differentiation by selectively activating the thrombopoietin receptor, thereby increasing platelet production. The drug is mainly used to treat thrombocytopenia related to chronic liver disease and patients who require low platelets before invasive procedures. It can effectively reduce the risk of bleeding and improve the safety of treatment.

Avatrombopag is an oral tablet, and the commonly used specifications are 20mg or 40mg. The standard recommended dose varies according to different indications: for patients with chronic liver disease-related thrombocytopenia, medication is usually started 10 to 13 days before planned invasive procedures, once a day, and the dose is adjusted based on the patient's weight and baseline platelet level; for patients who need to maintain platelet levels for a long time, continuous oral administration can be performed under the guidance of a doctor.

While patients are taking avatrombopag, individualized adjustments are required based on platelet count, body weight, and treatment response. If the platelet increase is insufficient, the dose can be increased appropriately under the guidance of a doctor; if the platelet level is too high or there is a risk of thrombosis, the dose needs to be reduced or the medication needs to be temporarily discontinued. Platelet levels should be monitored regularly during treatment, usually weekly or according to patient conditions, to ensure that platelets are maintained within a safe range (usually 50-150×10⁹/L) to avoid bleeding or thrombotic events.

Avatrombopag should be taken strictly on time under the guidance of a doctor, and the dose should not be increased or decreased at will. During medication, patients should pay attention to observe whether abnormal bleeding, skin ecchymosis or thrombosis symptoms, such as leg swelling, pain or difficulty breathing, etc., should seek medical attention immediately if they occur. Eating a reasonable diet, avoiding excessive alcohol consumption, and regularly reviewing platelet and liver function can help optimize efficacy and safety. At the same time, patients should inform their doctors of all medications they are taking to prevent potential drug interactions.

Reference materials:https://www.drugs.com/